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Long non-coding RNAs (lncRNAs) are new players in various biological processes. However, under-
standing of lncRNAs is still in its infancy. Here, we proposed an integrative method to identify epi-
genetically regulated lncRNAs and their associated genes. By combining RNA-seq data and ChIP-seq
data for histone H3 trimethylated at lysine 4 (H3K4me3) and H3K27me3, we identiﬁed 699
H3K4me3-regulated and 235 H3K27me3-regulated lncRNAs, each with an average of 238 and 307
associated genes, respectively. By analyzing Polycomb repressive complex 2 (PRC2) binding maps,
we observed that the negatively related genes of most epigenetically regulated lncRNAs were
enriched for PRC2-binding genes. In addition, through enrichment analysis, we inferred some lncR-
NAs with aberrant epigenetic modiﬁcations in glioblastoma and Alzheimer’s disease. Together, we
describe a method for the analysis of lncRNAs and demonstrate how integration of multi-omics data
can improve understanding of lncRNAs.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
With the emergence of next-generation sequencing technolo-
gies, the characterization of mammal transcriptome is allowed at
an unprecedented resolution [1]. Genome-wide transcriptome
analyses have revealed that almost the entire genome is tran-
scribed to some degree [2], however, only a minority of transcripts
can be translated into proteins [3]. Among the human genomic
regions without protein-coding potential, thousands of long non-
coding transcripts (lncRNAs) are identiﬁed [4].
LncRNAs are emerging as a class of important regulatory mole-
cules showing developmental and tissue-speciﬁc expression
patterns [5]. Accumulating evidence has shown that lncRNAs par-
ticipate in many essential biological processes, such as genomic
imprinting, maintenance of pluripotency, immune response and
development [6]. Moreover, recent studies have linked lncRNAs
to human diseases, such as neurodegenerative disorders, cardio-
vascular diseases and cancers [7]. They demonstrate that aberrantlncRNA expression may be a major contributor to the pathogenesis
of disease [8,9].
However, the regulation of lncRNA expression has so far been
poorly addressed relative to protein-coding genes (PCGs) [6]. A
large number of studies have been carried out to analyze the reg-
ulation of PCGs, and demonstrate that epigenetic modiﬁcations of
their promoters can substantially inﬂuence chromatin structure
and, in turn, control their expression [10–12]. Recent studies per-
formed genome-wide analysis of the epigenetic modiﬁcations of
lncRNAs in different cell and tissue types and revealed that lncR-
NAs showed similar epigenetic modiﬁcation patterns as PCGs
[13–15]. They observed that active histone H3 trimethylated at
lysine 4 (H3K4me3) and histone H3 trimethylated at lysine 36
(H3K36me3) were both enriched in highly expressed lncRNAs,
whereas Polycomb-mediated histone H3 trimethylated at lysine
27 (H3K27me3) was enriched in lowly expressed lncRNAs. In
addition, genome-wide epigenetic modiﬁcation was also used to
identify novel lncRNAs [16]. These ﬁndings highlighted that
epigenetic modiﬁcations may critically contribute to the regulation
of lncRNA expression.
Emerging evidence indicates that lncRNAs play various impor-
tant roles in global gene regulation, such as sensory, guiding and
scaffolding capacities [17]. LncRNAs can recruit chromatin-modify-
ing complexes to speciﬁc genomic loci for modulating chromatin
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[18]. Recently, genomic maps of a few lncRNAs demonstrated that
lncRNAs could occupy many genomic sites [19]. Another part of
lncRNAs, such as HOX transcript antisense RNA (HOTAIR), can
serve as a scaffold for histone modifying complexes and guide
them to their targets for silencing expression through H3K4
demethylation and H3K27 methylation [19,20]. Some lncRNAs,
such as GAS5, can act as decoys for gene repression [21]. Besides,
lncRNAs can also form RNA–RNA interaction for changing RNA
structures [22]. Such complex regulatory mechanisms [23] impede
the comprehensive characterization of regulatory targets of
lncRNAs.
It should be noted that both epigenetic modiﬁcation and target-
ing regulation can be involved in the regulation of many important
biological processes [24]. Epigenetic alterations can transcription-
ally activate or silence some key regulators (such as transcription
factors and lncRNAs). In such case, increased (or decreased)
expression of these regulators mediated by epigenetic alterations
can subsequently affect their downstream targets by various tar-
geting mechanisms [25]. For example, ZEB1, an important tran-
scription factor, has been associated with the transition during
development and the regulation of the epithelial-mesenchymal
transition (EMT). When the ZEB1 promoter converts from a biva-
lent to active chromatin state, its increased expression leads to
expression changes of many differentiation-related genes by direct
and indirect means, which in turn drives the generation of cancer
stem cells [26]. A recent study reported that a lncRNA DLX1AS
can function as a key determinate of neurogenesis by converting
from a bivalent to active chromatin state during neuronal differen-
tiation [27]. The epigenetic alteration results in the increased
expression of DLX1AS, which then induce an increase in the
expression of its protein-coding gene neighbors, DLX1 and DLX2,
two important transcription factors in neuron differentiation [28].
Based on the above evidence, it is reasonable to assume that
epigenetic alterations at the promoters of lncRNAs can change
their expression levels, and in turn inﬂuences the expression of
their downstream target genes by direct and indirect means
(Fig. 1). Such cascade relationships allow us to identifyFig. 1. Epigenetic-mediated cascade relationship. Epigenetic alterations at lncRNA promo
by direct and indirect means.epigenetically regulated lncRNAs and their affected targets whose
expression is dynamically dependent on epigenetic states at
lncRNA promoters. Notably, both direct and indirect targets of
lncRNAs can be inﬂuenced by lncRNA expression changes through
information ﬂow in complex regulatory network. Such direct and
indirect effects have been reported in transcription factors and
miRNAs [29–31]. Thus, these direct and indirect targets should
show similar dependence of expression on epigenetic states of
lncRNA promoters. We referred to the direct and indirect targets
as the relevant genes of lncRNAs. Based on the above consider-
ation, we combined transcriptome from RNA-seq data and epige-
nome from ChIP-seq data across numerous human cell lines to
identify a particular type of cascade relationship in which epige-
netic alterations at lncRNA promoters inﬂuence the expression of
lncRNAs and in turn change the expression of their relevant genes.
Subsequently, we used the relevant genes of epigenetically regu-
lated lncRNAs to characterize the functions of these lncRNAs. In
addition, using expression proﬁles of PCGs from glioblastoma
(GBM) and Alzheimer’s disease (AD), we inferred GBM- and AD-
associated lncRNAs with aberrant epigenetic modiﬁcations, whose
relevant genes were signiﬁcantly enriched in differentially
expressed genes.
2. Materials and methods
2.1. Data resource
The RNA-seq data for 27 cell lines (22 were paired-end
sequenced and 5 were single-end sequenced) were downloaded
from Gene Expression Omnibus (GEO) (Table S1). Of these
RNA-seq data, 20 were obtained from the ENCODE Consortium
(GSE 30567), and the other 7 were collected from different studies
(GSE52657, GSE30786, GSE52447, GSE37061, GSE43070, GSE
45428, SPX209063 and SPX209064).
A total of 74 ChIP-seq data referring to two epigenetic marks
(H3K4me3 and H3K27me3) and their corresponding input controls
in the 27 cell lines were used (Table S2). Among these cell lines,
ChIP-seq data for H3K4me3 in 27 cell lines and ChIP-seq data forters can inﬂuence their expression and in turn affect their downstream target genes
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Consortium (GSE35583 and GSE29611).
The exon structures of PCGs and lncRNAs were obtained from
the UCSC Gene track and GENCODE (v16), respectively. The pro-
moter regions of lncRNAs were deﬁned as the regions 2.5 kb
upstream to 0.5 kb downstream of the transcription start sites
(TSSs) of lncRNAs.
2.2. Construction of transcriptional and epigenetic proﬁles in diverse
cell lines
For RNA-seq data, sequencing reads were aligned to the human
genome (GRCh37/hg19) using TopHat (version 2.0.8) [32], with
default parameters. Output BAM ﬁles for these cell lines were used
for computation of gene expression. Using a customized script in R
that compared the genomic locations of reads with the exon loca-
tions of PCGs and lncRNAs, reads having at least one base overlap-
ping with gene exons and uniquely matched to one gene were
kept. Then, read counts for each gene (including PCGs and lncR-
NAs) across the 27 cell lines were calculated. Using DESeq2 (R
package, version 1.2.10) [33], we normalized read counts for subse-
quent analyses.
For each ChIP-seq data, raw sequence reads were aligned to the
human reference genome (GRCh37/hg19) using Bowtie (version
0.12.9) [34], with the ﬁrst 28 bases as the ‘‘seed’’ region and allow-
ing up to 2 mismatches. Only uniquely mapped reads were
retained and duplicate reads were ﬁltered out. Reads were then
extended by 200 bp in the 30 direction. The levels of H3K4me3
and H3K27me3 at lncRNA promoters from ChIP-seq and input-
DNA data were calculated using the RPKM method (reads per kilo-
base per million mapped). To alleviate the effects of noise, we
added a pseudocount as in [35]:
RPKM¼ reads in lncRNA promoterþ pseudocounts
length of lncRNA promoterðkbÞmapped readsðmillionÞ
pseudocount ¼mapped readsðmillionÞ
p
where p is the pseudocount factor, which is set to 2. Then, for each
lncRNA promoter the H3K4me3 and H3K27me3 levels were calcu-
lated as the log2 ratio of RPKM between ChIP and input.
2.3. Identiﬁcation of epigenetically regulated lncRNAs and their
relevant genes
Based on the assumption that epigenetic alterations at the pro-
moters of lncRNAs can change their expression levels and in turn
inﬂuences the expression of their relevant genes, we proposed a
method to capture a particular type of cascade relationship com-
posed of epigenetically regulated lncRNAs and their relevant genes
whose expression is correlated with epigenetic states at the pro-
moters of lncRNAs.
For the transcriptional proﬁle across different cell lines, lncR-
NAs and PCGs which expressed in less than 8 cell lines were
removed and the top 30% with stable expression (evaluated by
standard deviation) were ﬁltered. For the epigenetic proﬁle, lncR-
NAs with detected epigenetic signals in less than 8 cell lines were
removed. And negative values of epigenetic levels were set to 0. For
each lncRNA, we divided samples into two groups according to epi-
genetic modiﬁcation levels at the lncRNA promoter (one with high
epigenetic levels and the other with low levels), and then calcu-
lated expression difference of the lncRNA and PCGs. For details,
we ranked cell lines in ascending order according to its histone
modiﬁcation levels and then re-arranged the expression proﬁle
based on the order. Next, we chose each position in the rank orderlist to divide the cell lines into two groups (each group should con-
tain at least four cell lines): one group with lower epigenetic levels
at the promoter of this lncRNA and the other group with higher
epigenetic levels. For a given division, we used DESeq2 package
[33] to investigate whether this lncRNA showed signiﬁcantly dif-
ferential expression and to identify differentially expressed PCGs
based on their read count data with fold change (FC) > 2 and false
discovery rate (FDR) < 0.01. The expression of this lncRNA was
required to have a positive (or negative) correlation with the ele-
vated H3K4me3 (or H3K27me3) levels. After performing differen-
tial analyses for all divisions, we determined in which divisions
the lncRNA was differentially expressed (termed epigenetically
regulated lncRNA) and the corresponding differentially expressed
PCGs were recorded. Finally, for this epigenetically regulated
lncRNA, common differentially expressed PCGs in the recorded
divisions were regarded as the relevant genes of this lncRNA. The
relevant genes whose expression was positively correlated with
the expression of epigenetically regulated lncRNAs were termed
positively related genes and the ones with negative correlations
were termed negatively related genes.
2.4. Prediction of disease-related lncRNAs with aberrant epigenetic
modiﬁcation
We expected that the relevant genes of a disease-related
lncRNA should show signiﬁcant expression changes in disease. To
identify disease-related lncRNAs, we calculated t statistics for all
genes by comparing disease and normal samples using a speciﬁc
disease-related expression dataset. According to the t statistics,
all genes were ranked. Based on the ranking list, we identiﬁed
lncRNAs with signiﬁcant enrichments of their positively/negatively
related genes for dysregulated genes by gene set enrichment anal-
ysis (GSEA, v2.0) [36], with FDR < 0.05. For a speciﬁc epigenetic
mark, if the relevant genes of a given lncRNA were signiﬁcantly
enriched in the top or bottom of the ranking list, this lncRNA
was thought to be disease-related, with aberrant modiﬁcation of
this epigenetic mark.
2.5. Functional enrichment analysis
We performed functional enrichment analysis for the relevant
genes of each lncRNA using the hypergeometric distribution test
(implemented in the Bioconductor software GOstats package)
based on Gene Ontology (GO), with FDR < 0.05. Only GO terms
occurring at level 4 or greater in the biological process (BP) branch
were extracted.
3. Results
3.1. Construction of transcriptome and epigenome of lncRNAs across
cell lines
To comprehensively characterize transcriptome of lncRNAs, we
obtained RNA-Seq data of 27 distinct human cell lines generated
by different laboratories. Through mapping more than 3.3 billion
sequence reads to the human genome, transcriptome of lncRNAs
across these human cell lines was constructed based on a standard
processing pipeline (see Section 2). We compared the transcrip-
tome data with that generated by exon arrays (derived from the
same platform, GSE19090) in ﬁve cell lines. The Pearson correlation
coefﬁcients (PCCs) were between 0.73 and 0.82 (P values < 2.2e-16)
(Figs. 2a and S1), indicating the reliability of RNA-seq data even
from different laboratories [37]. Analyzing the transcriptome of
the 27 cell lines, we found that the majority of PCGs (54.4%)
expressed in all cell lines and few (1.5%) expressed exclusively in
Fig. 2. Transcriptome and epigenome of lncRNAs and PCGs. (a) Scatter plot shows the expression values (log2 transformed) detected using RNA-seq and microarray in
epithelial colorectal adenocarcinoma (Caco-2) cells. (b) Frequency distributions of lncRNAs (top) and PCGs (bottom) present in different numbers of cell lines. (c) The
distributions of expression of lncRNAs and PCGs in 27 cell lines. Each line represents the expression distribution of lncRNAs (red) and PCGs (blue) in one cell line. (d) The
distributions of H3K4me3 and H3K27me3 levels at lncRNA promoters in 27 and 18 cell lines, respectively. Each line represents the distribution of H3K4me3 (orange) and
K3K27me3 (green) in one cell line. (e) Transcriptional proﬁle of lncRNAs across 27 cell lines (left), and epigenetic proﬁles of H3K4me3 (middle) and H3K27me3 (right) at
lncRNA promoters across 27 and 18 cell lines, respectively.
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expressed in all cell lines and 11% expressed in only one of the cell
lines (Fig. 2b). Moreover, lncRNAs showed substantially lower
expression than PCGs in all cell lines (Fig. 2c).
To characterize epigenetic regulation of lncRNAs, we con-
structed two histone modiﬁcation proﬁles of H3K4me3 and
H3K27me3 for lncRNA promoters based on their ChIP-seq data in
27 and 18 cell lines, respectively. Almost all lncRNAs had low
H3K27me3 levels at their promoters (Fig. 2d). Interestingly, we
observed that a fraction of lncRNAs showed high H3K4me3 levels
at their promoters although most had low H3K4me3 levels
(Fig. 2d). Furthermore, the H3K4me3 modiﬁcations at lncRNA
promoters seemed to show a similar pattern with the lncRNA
expression, while the H3K27me3 exhibited a cell type-speciﬁc dis-
tribution (Fig. 2e), suggesting different roles of distinct epigenetic
marks in lncRNA expression. By calculating the PCCs between his-
tone modiﬁcation levels and expression levels for lncRNAs and
PCGs in three cell lines (including GM12878, H1 and Hela-S3),
we found that both lncRNAs and PCGs showed signiﬁcant correla-
tions, although relatively lower correlations were observed in lncR-
NAs than PCGs. The PCCs between H3K4me3 signal and expression
ranged from 0.68 to 0.80 for PCGs (P values < 2.2e-16) and from
0.46 to 0.49 for lncRNAs (P values < 2.2e-16) (Fig. S2). The PCCsbetween H3K27me3 signal and expression ranged from 0.13 to
0.57 for PCGs (P values < 2.2e-16) and from 0.03 to 0.33 for
lncRNAs (P values < 2.2e-16) (Fig. S3). These results suggest that
lncRNAs may be subjected to epigenetic regulation resembling
PCGs.
3.2. Identiﬁcation of epigenetically regulated lncRNAs and their
relevant genes
The correlation between epigenetic modiﬁcation and lncRNA
expression suggests that epigenetic alterations at the promoters
of lncRNAs can inﬂuence their expression, which can in turn lead
to expression changes of their relevant genes [14,38]. By combin-
ing the transcriptome and epigenome, we developed a method to
identify epigenetically regulated lncRNAs and their relevant genes
(Fig. 3, see Section 2 for details). Brieﬂy, the method identiﬁes dif-
ferentially expressed lncRNAs and PCGs between two groups of
samples with different epigenetic states at lncRNA promoters—
one with high epigenetic modiﬁcation levels and the other with
low epigenetic modiﬁcation levels. The differential lncRNAs were
termed epigenetically regulated lncRNAs. For a given epigeneti-
cally regulated lncRNA, PCGs whose expression is associated with
not only the expression of the lncRNA but also the epigenetic state
Fig. 3. Overview of the method to identify epigenetically regulated lncRNAs and their relevant genes.
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for active epigenetic marks (H3K4me3), lncRNAs should show
upregulation of expression in response to increased epigenetic sig-
nals, while, for repressive epigenetic marks (H3K27me3), lncRNAs
should show downregulation of expression.
Applying the method to expression and epigenetic proﬁles
across these cell lines, we identiﬁed 699 H3K4me3-regulated lncR-
NAs with a total of 8751 relevant genes and 235 H3K27me3-regu-
lated lncRNAs with a total of 7151 relevant genes. The average
numbers of relevant genes for H3K4me3-regulated and
H3K27me3-regulated lncRNAs were 238 (ranged from 1 to 2239)
and 307 (ranged from 3 to 1520), respectively (Fig. S4, Tables S3
and S4). In total, there were 851 epigenetically regulated lncRNAs
(6.4% of all lncRNAs) and 9274 relevant genes (49.1% of all PCGs), of
which 6628 were commonly affected by H3K4me3- andH3K27me3-regulated lncRNAs. The average number of relevant
genes per epigenetically regulated lncRNA was 255.
We next set out to provide an overview of the properties of epi-
genetically regulated lncRNAs. Notably, only a fraction of lncRNAs
were found to be linked with epigenetic marks (26.8% of lncRNAs
in the H3K4me3 proﬁle and 13.0% of lncRNAs in the H3K27me3
proﬁle). Interestingly, these epigenetically regulated lncRNAs dis-
played a higher degree of conservation (evaluated by 46-way
phastCons vertebrate conserved elements from UCSC) than other
lncRNAs (P values < 0.01, Wilcoxon rank sum test, Fig. 4a), suggest-
ing important functions of these epigenetically regulated lncRNAs.
We divided these epigenetically regulated lncRNAs into three clas-
ses (including antisense, overlapping and intergenic) according to
their genomic locations. We observed that the majority of the
epigenetically regulated lncRNAs were from intergenic regions,
Fig. 4. Characterization of epigenetically regulated lncRNAs and their relevant genes. (a) Cumulative distributions of sequence conservation for lncRNAs regulated by
H3K4me3 and/or H3K27me3 (red), lncRNAs not regulated by the two epigenetic marks (green) and other lncRNAs that were ﬁltered out during the identiﬁcation of
epigenetically regulated lncRNAs (blue, see Section 2). Sequence conservation of lncRNAs was estimated using the average phastCon scores based on genomic sequence
comparison among 46 vertebrate species. (b) Proportions of different lncRNA classes in H3K4me3-regulated lncRNAs, H3K27me3-regulated lncRNAs and all known lncRNAs.
(c) Bar plots showing the H3K4me3 (top) and H3K27me3 (bottom) levels of HOTAIR across 18 cell lines (PCC = 0.73, P value < 0.001). (d) Heatmaps representing the links
between epigenetically regulated lncRNAs and their relevant genes (right panel). Parallel bars on the left of the heatmaps represent the distributions of number of lncRNAs
associated with each PCG. (e) The percentage of epigenetically regulated lncRNAs showing signiﬁcant enrichments for EZH2 binding genes based on their real relevant genes
(red arrow) and randomly selected genes (gray curve). This permutation experiment has been repeated 1000 times to determine the empirical P values. Top panel for
H3K4me3 and bottom panel for H3K27me3.
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Also, we found 83 lncRNAs regulated by both H3K4me3 and
H3K27me3 (P value = 5.75e-48, hypergeometric test), most of
which with a complementary pattern of the H3K4me3 and
H3K27me3 signals across the common cell lines (such as HOTAIR
in Fig. 4c and other four lncRNAs in Fig. S5). Among these lncRNAs,
78 showed signiﬁcant overlap of relevant genes between
H3K4me3- and H3K27me3-mediated regulation (P values < 0.05,
Fisher’s exact test), suggesting similar relevant genes of lncRNAs
despite regulation by distinct epigenetic marks. In addition, the
links between epigenetically regulated lncRNAs and their relevant
genes were plotted as heatmaps (Fig. 4d, right panel). We investi-
gated the distributions of number of lncRNAs associated with each
PCG and found that most PCGs were related to a small number of
lncRNAs (Fig. 4d, left panel).
It has been shown previously that about 20% of lncRNAs in
human can interact with Polycomb repressive complex 2 (PRC2),
direct PRC2 to speciﬁc genomic sites and in turn silence gene
expression [39]. Therefore, we expected that the negatively related
genes would be signiﬁcantly enriched in PRC2-binding regions. To
address the question, we obtained and merged enhancer of zeste 2
(EZH2, the catalytic subunit of PRC2) binding peaks detected by
ChIP-seq data in ﬁve cell lines (including GM12878, H1, HepG2,
HSMM and NHEK) from UCSC. Then, we tested whether the
negatively related genes of lncRNAs were signiﬁcantly enriched
for EZH2 binding genes (Fig. S6, see Supplemental Information
for details). In brief, for each epigenetic mark, we ﬁrst calculatedthe percentage of epigenetically regulated lncRNAs whose nega-
tively related genes were signiﬁcantly enriched for EZH2 binding
genes (FDR < 0.05, hypergeometric test). As a result, 37.6% of
H3K4me3-regulated and 63% of H3K27me3-regulated lncRNAs
showed signiﬁcant enrichments. Among these signiﬁcantly
enriched lncRNAs, some known lncRNAs interacting with PRC2
were observed, such as HOTAIR and HOX antisense intergenic
RNA myeloid 1 (HOTAIRM1) [38,40]. To assess statistical signiﬁ-
cance, we subsequently performed a permutation test. For each
epigenetically regulated lncRNA, the same number of negatively
related genes was randomly selected. Then, we calculated the per-
centage of epigenetically regulated lncRNAs whose randomly
selected genes were signiﬁcantly enriched for EZH2 binding genes.
This process was repeated 1000 times, resulting in a null distribu-
tion of the percentage values. Empirical P values were established
by counting how many times the permuted percentage values
were greater than, or equal to, the observed one in the true data
set. Our results showed that the negatively related genes of epige-
netically regulated lncRNAs were signiﬁcantly linked with EZH2
binding (P value < 0.001 for H3K4me3- and H3K27me3-regulated
lncRNAs, Fig. 4e), further validating the relevant genes of these
lncRNAs.
3.3. Functional enrichment of relevant genes
To further validate the relevant genes of epigenetically
regulated lncRNAs, we reasoned that the relevant genes could
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ment analysis of the relevant genes for each lncRNA, we observed
that both of the H3K4me3- and H3K27me3-regulated lncRNAs
were predominantly involved in immune-related functions
(Fig. 5a), in line with previous reports [16,41]. Besides, the relevant
genes of certain lncRNAs were found to be involved in their known
functions. For example, H19, a 2.3-kb long non-coding RNA, is
imprinted in mouse and human. We identiﬁed 37 and 20 relevant
genes for H19 regulated by H3K4me3 and H3K27me3, respectively.
Both of the relevant gene sets were signiﬁcantly enriched in mus-
cle-related biological processes (Fig. 5b). Consistently, previous
studies have reported that H19 expressed exclusively in skeletal
muscle and heart, and might be involved in muscle cell differenti-
ation [42]. HOTAIR, a well-characterized lncRNA, has been found to
be involved in the development of cancer [38,43]. We found that
the relevant genes of HOTAIR were involved in many cancer-
related cellular processes, such as inﬂammatory response
(H3K4me3-regulated) and cell junction organization (H3K27me3-
regulated) (Fig. 5c).
3.4. Predicting disease-related aberrantly epigenetically regulated
lncRNAs based on their relevant genes
The alteration of lncRNA expression has been observed to be
associated with disease etiology [44,45]. However, to date, only a
few lncRNAs have been implicated in human disease [46]. These
relevant genes of epigenetically regulated lncRNAs could be used
to reﬂect the states of lncRNAs in speciﬁc contexts. Thus, if the
relevant genes of a speciﬁc lncRNA show signiﬁcantly abnormal
expression in speciﬁc diseases, it may indicate aberrant epigenetic
modiﬁcation of this lncRNA. To predict aberrantly epigenetically
regulated lncRNAs in disease, we used GSEA to examine whether
the relevant genes of epigenetically regulated lncRNAs show signif-
icant expression changes based on disease-related gene expression
data.Fig. 5. Functional analysis of the relevant genes of epigenetically regulated lncRNAs. Usi
by relevant genes of each lncRNA were determined. (a) Top 20 GO terms with the highest
The enriched GO terms of H19 (b) and HOTAIR (c) based on their relevant genes.3.4.1. Case 1: identiﬁcation of aberrantly epigenetically regulated
lncRNAs in GBM
A GBM exon array data set was obtained from French et al.
(GSE9385) [47], consisting of 26 GBM and 6 normal samples. By
comparing disease and normal expression data, we ranked PCGs
according to their t statistics. GSEA was used to determine whether
the positively and negatively related genes of epigenetically regu-
lated lncRNAs are enriched in the top or bottom of rank-ordered
list of PCGs (see Methods for details). In the results, we identiﬁed
372 H3K4me3-regulated lncRNAs with signiﬁcant enrichments
(245 based on positively related genes and 221 based on negatively
related genes, with 94 in common), and 149 H3K27me3-regulated
lncRNAs (112 based on positively related genes and 84 based on
negatively related genes, with 47 in common) (Table S5). To vali-
date these abnormal lncRNAs, we re-annotated the exon array
probes and constructed the expression proﬁle of 10092 lncRNAs
as in [48]. Then, we identiﬁed 468 differentially expressed lncRNAs
(FC > 1.5 and FDR < 0.05) using t-test and found a signiﬁcant
overlap with the aberrantly epigenetically regulated lncRNAs (P
value = 7.69e-13, chi-square test, Fig. 6a). Another two GBM
expression data sets were also used to predict aberrantly epigenet-
ically regulated lncRNAs. One data set containing 528 GBM and 10
normal samples was obtained from the The Cancer Genome Atlas
(TCGA) project, and the other including 10 GBM stem cells (GSC)
and 2 controls was downloaded from GEO with the accession num-
ber GSE46016. Using the same process as described above, we
identiﬁed 146 H3K4me3-regulated and 88 H3K27me3-regulated
lncRNAs in the TCGA GBM data and 472 H3K4me3-regulated and
184 H3K27me3-regulated lncRNAs in GSC data (Table S5). For both
of the two histone marks, we revealed high consistency of the
predicted lncRNAs in the three GBM-related expression datasets
(P value < 0.001, permutation test, Fig. 6b, see Supplemental Infor-
mation). As an example, HOTAIRM1 has been demonstrated to be
highly expressed in the fetal brain [49] and shows increased
expression in GBM [50]. Consistently, the re-annotation analysisng functional enrichment analysis (FDR < 0.05), the GO terms signiﬁcantly enriched
frequencies found in H3K4me3- (top) and H3K27me3-regulated (bottom) lncRNAs.
Fig. 6. Identiﬁcation of aberrantly epigenetically regulated lncRNAs in GBM. (a) Venn diagram showing the intersection between aberrantly epigenetically regulated lncRNAs
predicted in GBM (blue circle) and differentially expressed lncRNAs identiﬁed using GBM exon array data (red circle). (b) Venn diagram showing the number of aberrantly
epigenetically regulated lncRNAs identiﬁed in three GBM data (left for H3K4me3 and right for H3K27me3). (c) Enrichment plots for the positively (right) and negatively (left)
related genes of HOTAIRM1 sorted according to the differences between GBM and normal samples in the exon array data from GEO. The barcode plot indicates the position of
the relevant genes in the list of differentially expressed genes. Red and blue represent up- and down-regulation, respectively. (d) ChIP-seq tracks showing the density maps of
H3K4me3 in four human GBM stem cells and one normal neural stem cell.
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expression levels of HOTAIRM1 in GBM (FC = 5.9 and FDR <
4.07e-05). Our results showed that the positively and negatively
related genes of H3K4me3-regulated HOTAIRM1 were signiﬁcantly
enriched in the up-regulated and down-regulated genes, respec-
tively, in all three GBM datasets (Fig. 6c). By comparing ChIP-seq
data (in WIG format) of H3K4me3 between four human GBM stem
cells and one normal neural stem cell (GSE46014), we found obvi-
ous gain of H3K4me3 modiﬁcation at the promoter of HOTAIRM1
in GBM stem cells (Fig. 6d). These ﬁndings suggest that abnormal
H3K4me3 modiﬁcation of HOTAIRM1 may be an important event
contributing to the carcinogenesis of GBM.
3.4.2. Case 2: identiﬁcation of aberrantly epigenetically regulated
lncRNAs in AD
Many studies have demonstrated that a large proportion of
lncRNAs are extremely relevant in nervous system [51]. We
obtained an Alzheimer’s disease (AD) gene expression data from
Zhang et al. (GSE44772) [52], which referred to autopsied tissues
from dorsolateral prefrontal cortex (PFC), visual cortex (VC) and
cerebellum (CR) in brains of 129 AD patients and 101 non-demen-
ted healthy controls. Based on the relevant genes of epigenetically
regulated lncRNAs, we identiﬁed a large number of abnormal lncR-
NAs, including 411, 371 and 315 aberrantly H3K4me3-regulated
lncRNAs, and 184, 171 and 146 aberrantly H3K27me3-regulated
lncRNAs in PFC, VC and CR, respectively (Table S6). For example,
aberrantly H3K4me3-regulated GDNF-AS1 was identiﬁed in all
three AD datasets (Fig. 7a). In previous studies, GDNF-AS1 has been
demonstrated to be related to AD [53]. CDKN2B-AS1 (also knownas ANRIL) was a well-studied lncRNA and was reported to be dys-
functional in AD [51,54]. We found that the negatively related
genes of H3K4me3-regulated CDKN2B-AS1 were signiﬁcantly
enriched in the dysregulated genes in PFC and VC datasets
(Fig. 7b). For both of the two histone marks, we also revealed high
consistency of the aberrantly epigenetically regulated lncRNAs in
the three datasets (P value < 0.001, permutation test, Fig. 7c, see
Supplemental Information).
3.5. Comparison with other methods
In previous studies, using genome-wide epigenetic peaks
derived from ChIP-seq data, the lncRNAs that have at least one
peak overlapping the genomic regions around their TSSs were
referred to as epigenetically regulated lncRNAs. Based on the strat-
egy, Sati et al. [14] used various histone modiﬁcation ChIP-seq data
to reveal distinct patterns of epigenetically regulated lncRNAs. Wu
et al. [13] analyzed the relationships between epigenetic modiﬁca-
tion of lncRNAs and their expression. With regard to the relevant
genes of lncRNAs, a co-expression-based method has been widely
used [55–57]. Liao et al. calculated PCCs for each pair of lncRNA
and protein-coding gene, and identiﬁed the protein-coding genes
with P values 6 0.01 and PCCs ranked in the top or bottom 0.05%
as the relevant genes to explore the function of lncRNAs [58].
To compare with our approach, we combined the previous
methods to identify epigenetically regulated lncRNAs and their rel-
evant genes. As a result, 2066 H3K4me3-regulated and 405
H3K27me3-regulated lncRNAs were identiﬁed, each with an
average of 26 and 57 relevant genes, respectively. One well-known
Fig. 7. Identiﬁcation of aberrantly epigenetically regulated lncRNAs in AD. The enrichment plots for the relevant genes of GDNF-AS1 (a) using the PFC-related expression data
and CDKN2B-AS1 (b) using the VC-related expression data. (c) Venn diagram showing the number of aberrantly epigenetically regulated lncRNAs identiﬁed in three AD data
(left for H3K4me3 and right for H3K27me3).
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induce numerous diseases [59] was not identiﬁed. Subsequently,
we tested whether the negatively related genes were signiﬁcantly
enriched in PRC2-binding regions. We found that only 4% of
H3K4me3-regulated and 7.4% of H3K27me3-regulated lncRNAs
showed signiﬁcantly enrichments while our approach resulted in
37.6% and 63%, respectively. Functional enrichment analyses
showed that our method yielded more epigenetically regulated
lncRNAs with enriched functions (82% of H3K4me3-regulated
and 91.5% of H3K27me3-regulated lncRNAs) than the previous
method (27.5% of H3K4me3-regulated and 38% of H3K27me3-reg-
ulated lncRNAs). Specially, our results showed that HOTAIR was
signiﬁcantly involved in many known functions. For example, a
recent HOTAIR knockdown experiment [60] reported the associa-
tion of HOTAIR with inﬂammatory response that was identiﬁed
by our method but not by the previous method. Taken together,
these ﬁndings showed that our method was more effective in iden-
tifying epigenetically regulated lncRNAs and their relevant genes,
suggesting a better performance than the previous method.
4. Discussion
A large number of publicly available RNA-seq data and ChIP-Seq
data in different human cell types allow us to construct transcrip-
tome and epigenome and thus detect the complex relationships
between epigenetic modiﬁcation and expression. In this study,
we integrated many high-throughput sequencing data to proﬁle
the epigenetic modiﬁcation and expression of lncRNAs, and PCGexpression in 27 human cell lines. By capturing the relationships
between epigenetic modiﬁcations and expression, we identiﬁed
epigenetically regulated lncRNAs and their relevant genes. Our
results demonstrated that combining transcriptome and epige-
nome into a single framework had the ability to identify the genes
associated with lncRNAs and decipher which epigenetic marks reg-
ulate lncRNA expression and in turn inﬂuence their relevant genes.
Our method uses transcriptome and epigenome data to capture
epigenetic-mediated cascade relationships composed of epigeneti-
cally regulated lncRNAs and their relevant genes. Our method not
only considers the expression correlation between lncRNAs and
their relevant genes but also requires the dependence of expres-
sion of relevant genes on epigenetic modiﬁcation of lncRNAs. The
combination of regulations by lncRNAs and epigenetic marks allow
us to capture the indirect relationships between epigenetic states
of lncRNAs and expression of their relevant genes. Functional
enrichment analyses conﬁrmed the known functions of some lncR-
NAs. Further, epigenetically regulated lncRNAs showed clear evo-
lutionary conservation, indicating they may be under selection
pressure and have important biological functions. In addition, we
found that the relevant genes of most lncRNAs tend to be bound
by PRC2, suggesting that these relevant genes may be regulated
by lncRNA-mediated recruitment of epigenetic modifying
complexes. These ﬁndings demonstrated the feasibility of our
method for identiﬁcation of the relevant genes of epigenetically
regulated lncRNAs.
The relevant genes of epigenetically regulated lncRNAs can
characterize the functions of lncRNAs. It can also be used to predict
530 T. Zhao et al. / FEBS Letters 589 (2015) 521–531disease-related lncRNAs. By analyzing GBM and AD expression
data, we identiﬁed some potential disease-related lncRNAs. Fur-
thermore, our results showed that the abnormal expression of
the disease-related lncRNAs may be resulted from their aberrant
epigenetic modiﬁcation. For example, the relevant genes of
HOTAIRM1 (a H3K4me3-regulated lncRNA) were signiﬁcantly
enriched for differentially expressed genes in multiple GBM data-
sets. Previous studies revealed that HOTAIRM1 plays key roles in
myeloid differentiation through regulating the expression of the
homeobox transcription factor A (HOXA) genes [61]. It also showed
similar expression patterns to the HOXA genes in multiple tissues
[62]. The HOXA genes have been reported to be involved in cell
apoptosis and cell invasion, contributing to the pathogenesis of dif-
ferent types of cancer [63] and the development of human brain-
stem [64]. Notably, homeobox transcription factor A1 (HOXA1),
an oncogene, is not only the neighboring gene of HOTAIRM1 but
also a positively related gene of HOTAIRM1. We thus speculated
that activation of HOTAIRM1 mediated by abnormal H3K4me3
modiﬁcation might contribute to the development of GBM through
enhancing its cis-regulation to HOXA1. In the negatively related
genes of HOTAIRM1, we also found two genes, brain-speciﬁc angi-
ogenesis inhibitor 3 (BAI3) and alpha-2-HS-glycoprotein (AHSG),
that had been validated to be associated with cancer and showed
decreased expression in high-grade gliomas [65,66], indicating that
HOTAIRM1 may participate in tumorigenesis through controlling
other cancer-related genes in trans. In addition, our results showed
that hyaluronan synthase 2 (HAS2) was a positively related gene of
its natural antisense RNA (HAS2-AS1, a H3K4me3-regulated
lncRNA). They exhibit coordinated expression in the renal proximal
tubular epithelial cell [67]. The increasing of HAS2 can promote
tumor cell growth when hyaluronidase is activated [68]. Interest-
ingly, we observed that the relevant genes of HAS2-AS1 were sig-
niﬁcantly enriched in ECM-receptor interaction, which had a
close association with the accumulation of hyaluronan produced
by hyaluronan synthase in tumor stroma [69]. This indicates that
HAS2-AS1 may be an important regulator for HAS2 and thus a
potential cancer-associated lncRNA in GBM. Besides, b1 integrin
(ITGB1), a positively related gene of WWTR1-AS1 (a H3K4me3-reg-
ulated lncRNA), was related to focal adhesion, whose upregulation
has been reported in bevacizumab-resistant GBM and which may
mediate a mesenchymal-type resistance to antiangiogenic therapy
[70]. Another positively related gene of WWTR1-AS1, collagen type
I alpha 1 (COL1A1), was a useful marker for the diagnosis and prog-
nosis of GBM [71]. Such predicted GBM-related lncRNAs and their
relevant genes may help to explain the molecular mechanisms of
GBM, which are necessary to be further conﬁrmed in animal mod-
els or humans.
Taken together, based on the combination of epigenome and
transcriptome across different cell lines, we provided a computa-
tional method to identify epigenetically regulated lncRNAs and
their relevant genes. Our results will help to understand the func-
tions of lncRNAs and their roles in human diseases.
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